Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
A number of studies have assessed the efficacy of alglucosidase alfa as an enzyme
replacement therapy (ERT) on motor and respiratory endpoints in patients with late-onset …
replacement therapy (ERT) on motor and respiratory endpoints in patients with late-onset …
Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review
A Toscano, B Schoser - Journal of neurology, 2013 - Springer
Glycogen storage disease type 2/Pompe disease is a progressive muscle disorder with a
wide range of phenotypic presentations, caused by an inherited deficiency of acid alpha …
wide range of phenotypic presentations, caused by an inherited deficiency of acid alpha …
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience
AT van der Ploeg, ME Kruijshaar… - European journal of …, 2017 - Wiley Online Library
Background and purpose Pompe disease is a rare inheritable muscle disorder for which
enzyme replacement therapy (ERT) has been available since 2006. Uniform criteria for …
enzyme replacement therapy (ERT) has been available since 2006. Uniform criteria for …
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria
JN Spelbrink, FY Li, V Tiranti, K Nikali, QP Yuan… - Nature …, 2001 - nature.com
The gene products involved in mammalian mitochondrial DNA (mtDNA) maintenance and
organization remain largely unknown. We report here a novel mitochondrial protein …
organization remain largely unknown. We report here a novel mitochondrial protein …
Multi-system neurological disease is common in patients with OPA1 mutations
P Yu-Wai-Man, PG Griffiths, GS Gorman, CM Lourenco… - Brain, 2010 - academic.oup.com
Additional neurological features have recently been described in seven families transmitting
pathogenic mutations in OPA1, the most common cause of autosomal dominant optic …
pathogenic mutations in OPA1, the most common cause of autosomal dominant optic …
Mutations of mitochondrial DNA polymerase γA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia
E Lamantea, V Tiranti, A Bordoni, A Toscano… - Annals of …, 2002 - Wiley Online Library
One form of familial progressive external ophthalmoplegia with multiple mitochondrial DNA
deletions recently has been associated with mutations in POLG1, the gene encoding pol γA …
deletions recently has been associated with mutations in POLG1, the gene encoding pol γA …
[PDF][PDF] Changing oral health status of 6-and 12-year-old schoolchildren in Portugal
CM de Almeida, PE Petersen, SJ André… - Community dental …, 2003 - Citeseer
Aims To assess the actual oral health status of Portuguese schoolchildren aged 6 and 12
years according to gender and urbanisation, to highlight the trend over time in dental caries …
years according to gender and urbanisation, to highlight the trend over time in dental caries …
Phenotypic heterogeneity of the 8344A> G mtDNA “MERRF” mutation
Objectives: Myoclonic epilepsy with ragged-red fibers (MERRF) is a rare mitochondrial
syndrome, mostly caused by the 8344A> G mitochondrial DNA mutation. Most of the …
syndrome, mostly caused by the 8344A> G mitochondrial DNA mutation. Most of the …
Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients
M Guglieri, F Magri, MG D'Angelo, A Prelle… - Human …, 2008 - Wiley Online Library
Limb girdle muscular dystrophies (LGMD) are characterized by genetic and clinical
heterogeneity: seven autosomal dominant and 12 autosomal recessive loci have so far been …
heterogeneity: seven autosomal dominant and 12 autosomal recessive loci have so far been …
Syndromic parkinsonism and dementia associated with OPA1 missense mutations
Objective Mounting evidence links neurodegenerative disorders such as Parkinson disease
and Alzheimer disease with mitochondrial dysfunction, and recent emphasis has focused on …
and Alzheimer disease with mitochondrial dysfunction, and recent emphasis has focused on …